Wednesday, June 8, 2022

Lupin gets USFDA nod for generic drug

Lupin gets USFDA nod for generic drug The company has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Ivacaftor tablets, 150 mg strength, Lupin said in a statement.

from Moneycontrol Business News https://ift.tt/wtKJcX9

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...